|Bid||84.09 x 100|
|Ask||84.10 x 300|
|Day's Range||83.97 - 84.65|
|52 Week Range||66.93 - 86.90|
|PE Ratio (TTM)||31.58|
|Dividend & Yield||2.72 (3.27%)|
|1y Target Est||N/A|
For 2Q17, Alcon reported a 1.0% growth in revenues to $1.52 billion compared to $1.51 billion in 2Q16.
The first CAR-T therapy recently won a unanimous thumbs up for approval. But that doesn't mean CAR-T stocks are out of the woods just yet.
Global markets were weighed down by comments from the ECB and Bank of Japan even as bullish GDP data emerged from China this week